INDIANAPOLIS, Sept. 21, 2012 /PRNewswire/ -- Polymer Technology Systems, Inc. (PTS), the U.S.-based manufacturer of the CardioChek family of point-of-care diagnostic products, announced today that HEART UK has accepted CardioChek as the point-of-care system for lipid testing in a nationwide health screening program. HEART UK, the United Kingdom's (cholesterol) charity, works with the public and healthcare professionals to promote healthier lifestyles. HEART UK's acceptance of CardioChek as a screening tool is a significant milestone, as PTS continues to expand its presence in global markets.
The CardioChek test system provides on-site lipid panel screening tests and delivers readings for total cholesterol, HDL cholesterol, triglycerides, LDL (calculated), and glucose in less than two minutes. CardioChek is represented in the UK by BHR Pharmaceuticals Ltd., a specialty distributor of point-of-care medical diagnostics.
Andrew Greaves, Sales Director for BHR, said he is delighted that HEART UK has approved CardioChek as a screening tool in the national "Health-Check" program, and he is confident that HEART UK's acknowledgment will generate great interest within primary care organizations. Greaves continued, "As the Department of Health (UK) positions for greater awareness of the 'Health-Check' program, the drive to reduce the incidence of heart disease, and the need for reliable lipid testing in primary care, grows."
Robert Huffstodt, President and CEO of PTS, Inc. said, "We are honored by this important acknowledgement by HEART UK. Their organization is very much respected for the work they do in cholesterol awareness and testing, and HEART UK's recognition of the CardioChek system as a useful point-of-care screening tool is significant to our organization. With HEART UK's dedication to healthcare and our proficiency in providing fast, reliable test results, I am confident our partnership will effectively detect and help to moderate the risk factors for heart disease in the United Kingdom."
About HEART UK
HEART UK is registered as a charity with the Charity Commission (registered charity number 1003904) and as a company limited by guarantee with the Registrar of Companies (registered company number 02631049). HEART UK is an acronym, standing for Hyperlipidemia, Education, Atherosclerosis, and Research Trust UK.
Visit the website at www.heartuk.org.uk.
About BHR Pharmaceuticals, LTD
BHR Pharmaceuticals Limited specializes in point-of-care (POC) medical diagnostics in six major fields; allergy, cardiovascular, diabetes, female health, gastro-intestinal and hematology. BHR works with the leading diagnostic manufacturers of the world to bring quality products to the UK market. The products and services offered by BHR have proven to be of great value to healthcare teams. With active support from BHR, PCT's, GP's and pharmacies achieve service framework objectives in a meaningful, timely and cost-effective manner. Visit the website at www.bhr.co.uk.
About Polymer Technology Systems, Inc. (PTS, Inc.)
Polymer Technology Systems, Inc. (PTS, Inc.) is a global provider of point-of-care diagnostic products to the healthcare industry. Headquartered in Indianapolis, Indiana, PTS, Inc. manufactures products for distribution in over 120 countries around the world. The company has sales offices in Europe, Latin America and the Pacific Rim. PTS, Inc. products include the CardioChek® PA point-of-care device and the CardioChek Health Risk Assessment (HRA) software, that are marketed to the professional diagnostics industry and the consumer screening market. The company offers tests for a Lipid Panel, LDL Cholesterol, Glucose, Ketone, and other single and combination test strips for professional use with the CardioChek point-of-care device. Visit the website at www.cardiochek.com
All trademarks used or mentioned in this release are protected by law.
SOURCE Polymer Technology Systems, Inc.